TürkçeMalignancy is a medical term describing the presence of cancer cells that proliferate uncontrollably within body tissues and are capable of invading surrounding structures. Malignant tumors are pathological formations with a high growth potential, the ability to metastasize, and the potential to become life-threatening if left untreated.
The evaluation of masses or lesions with suspected malignancy involves clinical examination, imaging studies, and pathological assessments. This term indicates that findings suggestive of cancer have been identified within a tissue, although the diagnosis has not yet been definitively confirmed.
Malignant cellular changes associated with cancer development are characterized by genetic mutations, disruption of normal cell proliferation control, and the ability to invade surrounding tissues. During this process, cells escape normal growth regulation, form tumor tissue, and may impair organ function.
Confirmation of suspected malignancy through radiological and pathological examinations constitutes the cornerstone of the diagnostic process. Biopsy, histopathological analysis, and advanced imaging techniques enable differentiation between malignant and benign lesions and assist in determining the most appropriate treatment plan.
| What You Need to Know | Information |
| Definition of Malignancy | Malignancy refers to malignant (cancerous) tumors characterized by uncontrolled cell proliferation and the potential to invade surrounding tissues or spread to distant organs (metastasis). It is generally used synonymously with cancer. |
| Cellular Characteristics | Malignant cells have lost their normal cellular structure and function, accumulated genetic mutations, and acquired the ability to grow invasively and metastasize. |
| Difference Between Malignancy and Benignity | While benign tumors grow in a localized manner and do not spread, malignant tumors can invade surrounding tissues and metastasize to distant organs. |
| Examples of Malignancies | Malignancies may occur in many organs and systems, including lung cancer, breast cancer, colon cancer, leukemia, and lymphoma. |
| Definition of Suspected Malignancy | A preliminary clinical assessment indicating that a lesion or mass may be malignant based on clinical, laboratory, or imaging findings. |
| Findings That Raise Suspicion | Rapidly growing masses, irregularly bordered lesions, painless but firm masses, elevated cancer-related tumor markers, abnormal blood test results, or radiologically suspicious findings. |
| Diagnostic Methods | Further evaluation may be required when malignancy is suspected, including biopsy (the gold standard), computed tomography (CT), magnetic resonance imaging (MRI), PET-CT, blood tests, and histopathological examination. |
| Management of Suspected Malignancy | Careful evaluation of the suspicious finding, obtaining a biopsy from the lesion or tissue when necessary, and developing an appropriate treatment plan through multidisciplinary assessment are essential. |
| Treatment Approach | Once the diagnosis is confirmed, treatment options such as surgery, chemotherapy, radiotherapy, and immunotherapy may be selected according to the type and stage of the malignancy and the patient’s overall condition. |
| Importance | Suspected malignancy is a critical condition requiring prompt specialist evaluation and appropriate diagnostic testing to facilitate early diagnosis and treatment. |
What Is Malignancy and How Does It Develop at the Cellular Level?
In a healthy human body, cells function in a remarkably well-organized manner. They grow according to a specific plan, divide to reproduce, and when they complete their lifespan, they are eliminated by the body’s natural defense mechanisms and replaced with new cells. The process of malignancy begins when this precisely functioning system collapses at the cellular level. Severe damage occurs within the genetic code of the cell, namely its DNA, due to various causes. As a result of this damage, cells stop responding to the body’s biological signals that instruct them to stop dividing or to self-destruct.
This cellular abnormality not only causes cells to divide uncontrollably at an accelerated rate but also completely disrupts the normal architecture of tissues, profoundly impairing vital organ functions such as oxygen exchange and carbon dioxide elimination in the lungs. These malignant cells appear significantly different from normal healthy cells under the microscope. Their nuclei are abnormally enlarged, their shapes are irregular, and they possess the ability to evade the body’s immune system. These characteristics allow them to survive, grow, and form masses at their site of origin. Over time, these masses may travel through blood vessels or lymphatic channels to other parts of the body, a process known as metastasis. This transforms the disease from a localized problem into a systemic one.
What Types of Malignancies Arise from Different Tissues?
Cancer is not a single disease. Instead, it represents a broad group of disorders consisting of hundreds of subtypes classified according to their tissue of origin and cellular characteristics. In medical terminology, these diseases are named according to the tissue in which they first develop.
The primary categories include:
- Carcinomas
- Sarcomas
- Leukemias
- Lymphomas
- Myelomas
- Germ cell tumors
Among these groups, carcinomas account for approximately ninety percent of all cancer cases and are the most frequently encountered malignancies in thoracic surgery. Carcinomas arise from epithelial tissues that line the internal and external surfaces of organs. Lung cancer and breast cancer generally belong to this category. Tumors originating from connective tissue, muscle, fat, cartilage, or bone are called sarcomas. Masses arising from the ribs or muscles of the chest wall may belong to this group. Disorders involving blood cell production in the bone marrow are classified as leukemias, while diseases originating from the lymph nodes and lymphatic tissues of the immune system are called lymphomas. Myelomas, which arise from plasma cells, and germ cell tumors originating from reproductive cells also represent important categories in medical practice.
What Does the Malignancy Grade Mean?
After suspicious tissues or cells are removed through biopsy or surgery, they are carefully processed, stained with special dyes, and examined under the microscope by pathologists. During this meticulous evaluation, the tumor grade is determined. Known medically as the “grade,” this system measures how closely abnormal cells resemble healthy, normal cells. It is one of the most important indicators of how aggressively the disease is likely to behave, including how rapidly it may grow and spread.
Grade 1 tumors, also known as well-differentiated tumors, closely resemble their tissue of origin. They tend to grow more slowly and have a lower likelihood of spreading. In contrast, Grade 3 or Grade 4 tumors are poorly differentiated, meaning they have lost the structural appearance and functional characteristics of normal tissue. These highly abnormal cells display chaotic growth patterns and are biologically much more aggressive. They have a significantly greater capacity to invade surrounding tissues, requiring urgent, multidisciplinary, and often more extensive treatment strategies.
When Does Suspicion of Malignancy Arise in Thoracic Surgery?
Suspicion of malignancy involving the lungs, pleura, or thoracic cavity generally arises under two circumstances. In the first scenario, the patient seeks medical attention because of symptoms affecting daily life. In the second, an abnormal finding is detected incidentally during chest imaging performed for unrelated reasons, such as routine cardiac evaluation, preoperative assessment, or occupational health screening.
In thoracic medicine and thoracic surgery, evaluating these findings requires careful assessment of the patient’s overall risk profile. Age, particularly being over fifty years old, smoking history, occupational exposure to asbestos, silica, or industrial chemicals, and family history of cancer are all considered. When these risk factors coexist, even a tiny abnormality on imaging may warrant thorough investigation, as seemingly harmless lesions may represent the earliest manifestation of a serious disease.
What Are the Main Symptoms That Raise Suspicion of Malignancy?
Because the organs within the chest occupy a large anatomical space, tumors often develop silently and slowly. During the earliest stages, when the lesion remains very small, patients may have no symptoms. However, as the mass enlarges and begins compressing major airways, nerves, blood vessels, or the pleura, noticeable symptoms appear.
The principal warning signs include:
- Unexplained weight loss
- Persistent fatigue
- Persistent cough
- Shortness of breath
- Chest pain
- Bloody sputum
- Hoarseness
The presence of any of these symptoms, particularly when they persist for several weeks, requires careful medical evaluation. Rapid weight loss without dieting or profound fatigue unrelieved by rest may indicate increased metabolic activity associated with cancer. A cough lasting for weeks, progressive shortness of breath, sharp chest pain during deep breathing, hemoptysis, and persistent hoarseness resulting from compression of the recurrent laryngeal nerve are all findings that warrant prompt investigation.
Which Radiological Findings on CT Scans and Chest X-rays Raise Suspicion of Malignancy?
While standard chest X-rays remain valuable, overlapping anatomical structures may limit their diagnostic accuracy. Computed tomography provides detailed cross-sectional images and is considered the most reliable imaging modality for evaluating suspicious lesions.
Radiological findings that increase concern include:
- Large masses
- Irregular borders
- Spiculated margins
- Ground-glass opacities
- Part-solid lesions
- Rapid interval growth
Lesion size is an important risk factor. Lesions exceeding three centimeters are classified as masses and require further investigation. Smooth, round, well-defined margins generally suggest a benign process, whereas irregular or spiculated margins indicate invasive growth into surrounding tissues. Ground-glass opacities and part-solid nodules may represent early malignant cellular changes and therefore require close surveillance.
How Is Suspicion of Malignancy Managed in Pulmonary Nodules?
With widespread CT screening, pulmonary nodules are increasingly detected. A pulmonary nodule is defined as a rounded or oval lesion within the lung measuring less than three centimeters in diameter. Fortunately, most pulmonary nodules are benign scars from previous infections such as pneumonia or tuberculosis or represent harmless cellular accumulations.
Management depends largely on nodule size, appearance, and interval growth. Nodules smaller than five millimeters generally require only routine annual CT surveillance. Nodules measuring five to ten millimeters are followed more closely, often with repeat CT scans every three to six months. Nodules larger than ten millimeters may require PET imaging or tissue biopsy depending on their characteristics. Lesions exceeding twenty millimeters or demonstrating interval growth frequently require surgical evaluation without unnecessary delay.
Which Methods Are Used to Establish a Definitive Diagnosis When Malignancy Is Suspected?
When imaging findings and clinical features strongly suggest malignancy, obtaining tissue samples becomes essential for confirming the diagnosis, determining the tumor type, and assessing disease extent.
The principal diagnostic techniques include:
- Endobronchial ultrasonography
- Cervical mediastinoscopy
- Anterior mediastinotomy
- Transthoracic needle biopsy
- Minimally invasive surgical biopsy
Endobronchial ultrasonography combines bronchoscopy with ultrasound imaging, allowing physicians to visualize lymph nodes and masses located behind the airways in real time while simultaneously obtaining needle biopsy samples. Peripheral lung nodules may be sampled using CT-guided transthoracic needle biopsy. When these approaches fail to provide a diagnosis, minimally invasive surgical biopsy techniques are employed.
Which Surgical Treatments Are Performed Once Malignancy Has Been Confirmed?
Once pathology confirms malignancy or demonstrates a very high risk of cancer, surgery forms the foundation of curative treatment whenever appropriate. Modern thoracic surgery aims to completely remove diseased tissue while preserving as much healthy lung tissue as possible.
The principal surgical techniques include:
- Open thoracotomy
- Video-assisted thoracoscopic surgery
- Robotic surgery
- Lobectomy
- Segmentectomy
- Wedge resection
The surgical approach depends on tumor location and size. Traditional thoracotomy involves a large incision between the ribs. Today, however, minimally invasive techniques such as video-assisted thoracoscopic surgery have largely replaced open procedures. Lobectomy removes an entire lung lobe, whereas segmentectomy preserves more healthy tissue by removing only the affected anatomical segment. Wedge resection removes the lesion together with a margin of healthy surrounding tissue.
What Are the Advantages of Minimally Invasive Surgery in the Treatment of Malignancy?
One of the greatest advances in modern thoracic surgery has been the widespread adoption of minimally invasive techniques. Video-assisted thoracoscopic surgery and robotic surgery have transformed both the surgical experience and patient recovery.
Their primary advantages include:
- Small surgical incisions
- Less postoperative pain
- Shorter hospital stay
- Faster recovery
- Lower infection risk
- Reduced bleeding
- Improved cosmetic results
Unlike open surgery, minimally invasive procedures avoid forceful rib spreading, thereby minimizing damage to bones and muscles. Patients generally experience significantly less pain, allowing earlier deep breathing, coughing, walking, and faster restoration of normal lung function.
How Is Suspected Malignancy of the Pleura and Mediastinum Managed?
The thoracic cavity contains not only the lungs but also the mediastinum, which houses the heart and major blood vessels, and the pleura surrounding the lungs. Masses arising in these regions possess unique biological characteristics and require specialized diagnostic and treatment strategies.
In mediastinal tumors, lesion location and imaging characteristics provide valuable clues. Masses located behind the sternum often originate from the thymus gland. Biopsy is generally avoided because puncturing the tumor capsule may spread malignant cells throughout the chest cavity. Therefore, these tumors are usually removed intact. Pleural malignancies frequently present with pleural thickening and recurrent fluid accumulation. Individuals with previous asbestos exposure are particularly at risk. Diagnosis is established by obtaining tissue directly from the pleura or pleural fluid.
How Does Cancer Staging Influence the Treatment Plan?
After confirming malignancy, determining the exact extent of disease is the next essential step. The internationally accepted staging system evaluates tumor size, lymph node involvement, and distant metastases.
The major staging categories include:
- Early-stage disease
- Locally advanced disease
- Metastatic advanced disease
Staging determines the most appropriate treatment sequence. Early-stage disease is usually treated surgically. Locally advanced disease often requires chemotherapy or other systemic treatment before surgery. In metastatic disease, systemic therapies become the primary treatment approach.
Why Are Multidisciplinary Tumor Boards Important in the Management of Suspected Malignancy?
Modern cancer care requires collaboration among multiple medical specialists rather than decisions made by a single physician. Tumor boards bring together thoracic surgeons, medical oncologists, radiation oncologists, radiologists, nuclear medicine specialists, and pathologists to review every aspect of the patient’s condition.
This collaborative approach ensures that decisions regarding surgery, chemotherapy, radiotherapy, and other treatments are individualized and evidence-based. Whether a tiny incidental lung lesion or persistent symptoms raise suspicion of malignancy, timely diagnosis using appropriate technology followed by a personalized treatment strategy can be lifesaving.
Frequently Asked Questions
Prof. Dr. Alper Fındıkcıoğlu graduated from Istanbul University Faculty of Medicine and completed his thoracic surgery residency at Dr. Siyami Ersek Hospital. He began his academic career at Başkent University in 2005; he received the title of associate professor in 2014 and professor in 2022. He has extensive experience in lung cancer, chest wall diseases, and minimally invasive surgery. Since 2024, he has been continuing his professional work at Acıbadem Hospital.
